Abstract
Due to its unique anatomy, drug delivery to eye structures has always been problematic. Many efforts have been addressed to enhance ocular bioavailability by lowering non-specific interactions between drug and tissue, increasing drug stability or increasing the residence time in the case of topical drugs. In this context, nanotechnology has been a very helpful tool for developing suitable drug delivery systems. More specifically, different kinds of strategies in this field have been proposed to overcome the problems related to ocular administration. However, the success of a nanoparticulated system relies on the correct choice of the material which it is made of. Based on these statements, the present article offers a review of the most important biomaterials employed in nanostructured systems for ocular drug delivery, especially those designated to delivery to the ocular surface and their impact on the final activity of such systems.
Keywords: Eye, nanotechnology, nanoparticles, drug delivery, biomaterial.
Graphical Abstract
Current Organic Chemistry
Title:On the Biomaterials for Nanostructured Ocular Therapeutics
Volume: 19 Issue: 15
Author(s): Giovanni K. Zorzi, Jenny E. Parraga, Begona Seijo and Alejandro Sanchez
Affiliation:
Keywords: Eye, nanotechnology, nanoparticles, drug delivery, biomaterial.
Abstract: Due to its unique anatomy, drug delivery to eye structures has always been problematic. Many efforts have been addressed to enhance ocular bioavailability by lowering non-specific interactions between drug and tissue, increasing drug stability or increasing the residence time in the case of topical drugs. In this context, nanotechnology has been a very helpful tool for developing suitable drug delivery systems. More specifically, different kinds of strategies in this field have been proposed to overcome the problems related to ocular administration. However, the success of a nanoparticulated system relies on the correct choice of the material which it is made of. Based on these statements, the present article offers a review of the most important biomaterials employed in nanostructured systems for ocular drug delivery, especially those designated to delivery to the ocular surface and their impact on the final activity of such systems.
Export Options
About this article
Cite this article as:
K. Zorzi Giovanni, E. Parraga Jenny, Seijo Begona and Sanchez Alejandro, On the Biomaterials for Nanostructured Ocular Therapeutics, Current Organic Chemistry 2015; 19 (15) . https://dx.doi.org/10.2174/1385272819666150608215743
DOI https://dx.doi.org/10.2174/1385272819666150608215743 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Fixed Combination Efficacy Assessment in Patients with Secondary Neovascular Glaucoma and Diabetes Mellitus
Current Diabetes Reviews Glucose Lowering Activity of the Aqueous Extract of Warionia saharae in Normal and Diabetic Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry Theory and Application of Microdialysis in Pharmacokinetic Studies
Current Drug Metabolism Vascular Contribution to Alzheimer Disease: Predictors of Rapid Progression
CNS & Neurological Disorders - Drug Targets Study on the Slow-Release Mometasone Furoate Injection of PLGA for the Treatment of Knee Arthritis
Current Drug Delivery Emerging Risk Factors for Dementia: The Role of Blood Pressure Variability
CNS & Neurological Disorders - Drug Targets Neuroprotective Effects of Intravenous Anesthetics: A New Critical Perspective
Current Pharmaceutical Design Latest Advances in Breast Sonography
Recent Patents on Medical Imaging The Role of Omega-3 Polyunsaturated Fatty Acids Supplementation in Childhood: A Review
Recent Patents on Cardiovascular Drug Discovery An Overview of the Actions of Capsaicin and Its Receptor, TRPV1, and Their Relations to Small Primary Sensory Neurons
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke
CNS & Neurological Disorders - Drug Targets Smoking and Atherosclerosis: Mechanisms of Disease and New Therapeutic Approaches
Current Medicinal Chemistry Myocardial Energy Transport and Heart Failure
Current Cardiology Reviews Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: From Vascular Spasm to Cortical Spreading Depolarizations
Current Neurovascular Research Hybrid Stress Testing by Adenosine Infusion and Exercise Myocardial Perfusion Imaging: A Critical Appraisal
Current Cardiology Reviews Modeling Loss of Microvascular Wall Homeostasis during Glycocalyx Deterioration and Hypertension that Impacts Plasma Filtration and Solute Exchange
Current Neurovascular Research Clinical Applications of Transcranial Doppler Sonography
Reviews on Recent Clinical Trials Toxics of Tobacco Smoke and Cardiovascular System: From Functional to Cellular Damage
Current Pharmaceutical Design Exploiting Protein Phosphatase Inhibitors Based on Cantharidin Analogues for Cancer Drug Discovery
Mini-Reviews in Medicinal Chemistry The Changing Landscape of Voltage-Gated Calcium Channels in Neurovascular Disorders and in Neurodegenerative Diseases
Current Neuropharmacology